B. Carter

B. Carter, R. Hutchinson, R. K. Lewis, 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.

J. Gums, C. Coffey, Steven M. Smith, 2016, Journal of the American Society of Hypertension : JASH.

Antihypertensive Drug Utilization in Hypertensive Veterans With Complex Medication Profiles.

D. Malone, B. Carter, R. Dombrowski, 2000, Journal of clinical hypertension.

Pharmaceutical Care Services for Patients with Hypertension

B. Carter, A. Zillich, 2003, The Annals of pharmacotherapy.

Development of clinical pharmacy quality measures: A call to action

B. Carter, S. Nesbit, C. Haas, 2022, JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.

Clinical Pharmacy in Disease‐Specific Clinics

B. Carter, 2000, Pharmacotherapy.

Ambulatory Care Pharmacy Services: Has the Agenda Changed?

B. Carter, D. Helling, 2000, The Annals of pharmacotherapy.

Types of Interventions Made by Clinical Pharmacists in the IMPROVE Study

D. Malone, D. Covey, B. Carter, 2000, Pharmacotherapy.

Evaluation of excessive anticoagulation in a group model health maintenance organization.

D. Malone, D. Witt, B. Carter, 1998, Archives of internal medicine.

Assessing the structure and process for providing pharmaceutical care in Veterans Affairs medical centers.

D. Malone, B. Carter, R. Valuck, 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

The Clinical Pharmacy Specialist: Part of the Solution

R. Rudin, A. Rose, B. Carter, 2017, Journal of General Internal Medicine.

Labetalol (Trandate, Glaxo Inc.; Normodyne, Schering Corp.)

B. Carter, 1983 .

Dosing of Antihypertensive Medications in Patients with Renal Insufficiency

B. Carter, 1995, Journal of clinical pharmacology.

Equivalence of generic and brand-name drugs for cardiovascular disease.

B. Carter, 2009, JAMA.

Isolated systolic hypertension in older patients.

B. Carter, E. Furmaga, C. M. Murphy, 1993, Clinical pharmacy.

Physician–Pharmacist Collaborative Management of Asthma in Primary Care

Angela M. Wisniewski, E. MacLaughlin, C. Coffey, 2014, Pharmacotherapy.

Once‐Daily Propranolol for Hypertension: A Comparison of Regular‐Release, Long‐Acting, and Generic Formulations

G. O. Williams, B. Carter, L. Gersema, 1989, Pharmacotherapy.

Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.

D. Malone, D. Covey, B. Carter, 2000, Pharmacotherapy.

Potential use of aldose reductase inhibitors to prevent diabetic complications.

C. V. Abobo, B. Carter, D. Ball, 1990, Clinical pharmacy.

Development of a computer algorithm for defining an active drug list using an automated pharmacy database.

E. Chrischilles, M. Ernst, B. Carter, 2003, Journal of clinical epidemiology.

A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP.

Daniel K. Sewell, Linnea A. Polgreen, P. Polgreen, 2019, Contemporary clinical trials.

Thiazide Diuretics, Potassium, and the Development of Diabetes: A Quantitative Review

G. Bakris, B. Carter, A. Zillich, 2006, Hypertension.

Thiazide-induced hyperglycemia: can it be prevented?

M. Ernst, B. Carter, 2009, American journal of hypertension.

Extent of services provided by pharmacists in the iowa medicaid pharmaceutical case management program.

E. Chrischilles, B. Carter, N. Hayase, 2003, Journal of the American Pharmaceutical Association.

Influence of Patient Characteristics on Success of Ambulatory Blood Pressure Monitoring

G. Bergus, J. Dawson, M. Ernst, 2008, Pharmacotherapy.

Summative Evaluation of Physician-Pharmacist Collaboration Management

B. Carter, C. Parker, W. Mark, 2016 .

Antihypertensive therapy in the elderly.

B. Carter, 1989, Primary care.

Development of a centralized, remote clinical pharmacy service to enhance primary care

B. Levy, B. Carter, K. Kennelty, 2021, Pharmacy practice.

Phenytoin-induced hyperglycemia.

R. E. Small, B. Carter, R. Small, 1981, American journal of hospital pharmacy.

P-506: Physician adherence to JNC 7 guidelines and blood pressure control

Daniel W. Jones, G. Bakris, H. Black, 2005 .

Blood Pressure as a Surrogate End Point for Hypertension

B. Carter, Barry L Carter, 2002, The Annals of pharmacotherapy.

Dual Calcium-Channel Blocker Therapy in the Treatment of Hypertension

J. Saseen, B. Carter, 1996, The Annals of pharmacotherapy.

Pharmaceutical care for hypertensive patients.

B. Carter, 1994, American pharmacy.

Stroke Prophylaxis: Hypertension Management and Antithrombotic Therapy

B. Carter, K. Tortorice, Kathryn L. Tortorice, 1993, The Annals of pharmacotherapy.

Physician and pharmacist collaboration to improve blood pressure control.

Jeffrey D Dawson, Yinghui Xu, William R Doucette, 2009, Archives of internal medicine.

Interpreting the findings of the IMPROVE study.

D. Malone, D. Covey, B. Carter, 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Gastrointestinal Side Effects with Erythromycin Preparations

G. Milavetz, B. Carter, J. Woodhead, 1987, Drug intelligence & clinical pharmacy.

Team-Based Care with Pharmacists to Improve Blood Pressure: a Review of Recent Literature

L. Polgreen, B. Carter, K. Kennelty, 2018, Current Hypertension Reports.

Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge

K. Farris, B. Carter, T. Farley, 2014, International Journal of Clinical Pharmacy.

Antihypertensive drug interactions.

B. Carter, 2005, Drugs of today.

Combination Therapy in Hypertension

G. Bakris, J. Basile, A. Gradman, 2011, Journal of clinical hypertension.

ASH Position Article Combination therapy in hypertension

G. Bakris, J. Basile, A. Gradman, 2010 .

Combination therapy in hypertension.

G. Bakris, J. Basile, A. Gradman, 2010, Journal of the American Society of Hypertension : JASH.

A Cluster Randomized Trial to Evaluate Physician/Pharmacist Collaboration to Improve Blood Pressure Control

G. Bergus, J. Dawson, W. Doucette, 2008, Journal of clinical hypertension.

Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension.

A. Schutte, E. Schiffrin, G. Bakris, 2014, Journal of hypertension.

Clinical Practice Guidelines for the Management of Hypertension in the Community

John Chalmers, Samuel Mann, A. Schutte, 2014, Journal of clinical hypertension.

Bell's Palsy in an Older Patient with Uncontrolled Hypertension Due to Medication Nonadherence

S. Ellis, B. Carter, M. Leehey, 1999, The Annals of pharmacotherapy.

Relationship between physician knowledge of hypertension and blood pressure control.

G. Bergus, J. Dawson, W. Doucette, 2006, Journal of clinical hypertension.

Using theory to predict implementation of a physician-pharmacist collaborative intervention within a practice-based research network.

M. V. Vander Weg, C. Coffey, B. Carter, 2013, Research in social & administrative pharmacy : RSAP.

Designing Quality Health Services Research: Why Comparative Effectiveness Studies Are Needed and Why Pharmacists Should Be Involved

B. Carter, 2010, Pharmacotherapy.

Combination therapy in hypertension.

S. Oparil, G. Bakris, H. Black, 2010, Journal of the American Society of Hypertension : JASH.

Physician‐Pharmacist Co‐Management and 24‐Hour Blood Pressure Control

M. Ernst, B. Carter, G. Ardery, 2013, Journal of clinical hypertension.

Description of an Introductory Course Designed to Socialize Pharmacy Students

B. Carter, R. Valuck, C. Hatfield, 2000 .

Evolution of Clinical Pharmacy in the USA and Future Directions for Patient Care

B. Carter, 2016, Drugs & Aging.

Monitoring Digoxin Therapy in Two Long‐Term Facilities

B. Carter, R. Small, WILLIAM R. GARNETT, 1981, Journal of the American Geriatrics Society.

Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.

Jerome D. Cohen, M. Ernst, B. Carter, 2004, Hypertension.

Eplerenone — A Novel Selective Aldosterone Blocker

B. Carter, A. Zillich, 2002, The Annals of pharmacotherapy.

Guidelines for Therapeutic Interchange

M. Raebel, N. Schultz, M. O’Connell, 1993, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.

Underutilization of cardiovascular medications: effect of a continuity-of-care program.

K. Farris, B. Carter, T. Farley, 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Evaluation of Glipizide and Glyburide in a Health Maintenance Organization

B. Carter, D. Helling, M. Noyes, 1992, The Annals of pharmacotherapy.

Description of pharmacist interventions during physician–pharmacist co-management of hypertension

M. Ernst, B. Carter, J. Milchak, 2007, Pharmacy World & Science.

Establishing and Evaluating Clinical Pharmacy Services in Primary Care

W. Linn, B. Carter, A. Ellsworth, 1994, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.

Patient and Provider Perceptions of Hypertension Treatment: Do They Agree?

P. Kaboli, A. Ishani, B. Carter, 2007, Journal of clinical hypertension.

Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap.

C. Coffey, B. Carter, P. James, 2016, Hypertension.

T. Vaughn, B. Egan, C. Coffey, 2013, Journal of clinical hypertension.

Research Needs to Improve Hypertension Treatment and Control in African Americans

B. Davis, A. Go, P. Whelton, 2016, Hypertension.

The Iowa Continuity of Care study: Background and methods.

J. Dawson, P. Kaboli, K. Farris, 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Ambulatory Care Pharmacy Services: The Incomplete Agenda

B. Carter, D. Helling, B. L. Carter, 1992, The Annals of pharmacotherapy.

Hypertension and Endstage Renal Disease

B. Carter, T. Brown, 1994, The Annals of pharmacotherapy.

Pharmacist intervention for blood pressure control: medication intensification and adherence.

M. V. Vander Weg, C. Coffey, B. Carter, 2015, Journal of the American Society of Hypertension : JASH.

48 – Team-Based Care for Hypertension Management

B. Carter, 2018 .

Chapter 47 – Team-Based Care for the Management of Hypertension

B. Carter, 2013 .

The potency of team-based care interventions for hypertension: a meta-analysis.

Shimin Zheng, J. Daly, B. Carter, 2009, Archives of internal medicine.

Chapter 46 – Hypertension Disease Management Services

B. Carter, 2007 .

Strategies to improve the cardiovascular risk profile of thiazide-type diuretics as used in the management of hypertension

D. Sica, B. Carter, 2007, Expert opinion on drug safety.

Evaluation of Pharmacists' Work in a Physician‐Pharmacist Collaborative Model for the Management of Hypertension

Linnea A. Polgreen, B. Isetts, L. Polgreen, 2016, Pharmacotherapy.

A longitudinal analysis of antihypertensive drug interactions in a Medicaid population.

E. Chrischilles, B. Carter, B. Lund, 2004, American journal of hypertension.

Explicit and Implicit Evaluation of Physician Adherence to Hypertension Guidelines

G. Bergus, J. Dawson, Yoonsang Kim, 2007, Journal of clinical hypertension.

Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study)

J. Sutherland, B. Carter, A. Zillich, 2005, Journal of General Internal Medicine.

Efficacy of Patient Activation Interventions With or Without Financial Incentives to Promote Prescribing of Thiazides and Hypertension Control

M. V. Vander Weg, P. Kaboli, A. Christensen, 2018, JAMA network open.

Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease

E. MacLaughlin, C. Coffey, B. Carter, 2018, Pharmacotherapy.

Cost-utility analysis of physician–pharmacist collaborative intervention for treating hypertension compared with usual care

E. Chrischilles, B. Carter, N. Chaiyakunapruk, 2017, Journal of hypertension.

Primary Care Physician‐Pharmacist Collaborative Care Model: Strategies for Implementation

B. Carter, 2016, Pharmacotherapy.

Cost-Effectiveness of a Physician–Pharmacist Collaboration Intervention to Improve Blood Pressure Control

Linnea A. Polgreen, C. Coffey, Jayoung Han, 2015, Hypertension.

Sustained Blood Pressure Control Following Discontinuation of a Pharmacist Intervention for Veterans

M. V. Vander Weg, G. Rosenthal, B. Carter, 2015, Journal of clinical hypertension.

Cluster-Randomized Trial of a Physician/Pharmacist Collaborative Model to Improve Blood Pressure Control

T. Vaughn, B. Egan, C. Coffey, 2015, Circulation. Cardiovascular quality and outcomes.

Instrumental variable methods to assess quality of care the marginal effects of process-of-care on blood pressure change and treatment costs.

E. Chrischilles, B. Carter, J. Brooks, 2015, Research in social & administrative pharmacy : RSAP.

A Mixed‐Method Approach to Evaluate a Pharmacist Intervention for Veterans With Hypertension

M. V. Vander Weg, G. Rosenthal, B. Carter, 2014, Journal of clinical hypertension.

Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report

S. Oparil, W. Cushman, Sidney C. Smith, 2014 .

Institutional Review Board Barriers and Solutions Encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: A National Multicenter Practice‐Based Implementation Trial

Gail Ardery, E. MacLaughlin, D. Fike, 2013, Pharmacotherapy.

Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures.

Shimin Zheng, M. Ernst, B. Carter, 2010, Archives of internal medicine.

Physician Adherence to Blood Pressure Guidelines and Its Effect on Seniors

Matt T. Harmston, J. Dawson, B. Carter, 2008, Pharmacotherapy.

Measuring Adherence to Practice Guidelines for the Management of Hypertension: An Evaluation of the Literature

Gail Ardery, B. Carter, P. James, 2004, Hypertension.

Physician–Pharmacist Collaborative ManagementNovelty and Significance

C. Coffey, B. Carter, P. James, 2016 .

Patient and Physician Beliefs About Control over Health: Association of Symmetrical Beliefs with Medication Regimen Adherence

K. Wallston, P. Kaboli, G. Rosenthal, 2010, Journal of General Internal Medicine.

A cluster randomized trial to evaluate a centralized remote clinical pharmacy service in large, health system primary care clinics

Linnea A. Polgreen, Brian M. Gryzlak, M. V. Vander Weg, 2021, Journal of the American College of Clinical Pharmacy : JACCP.

Targeting of uncontrolled hypertension in the emergency department (TOUCHED): Design of a randomized controlled trial.

M. Daviglus, S. Kitsiou, H. Prendergast, 2021, Contemporary clinical trials.

Will Team‐Based Care Really Be Implemented?

B. Carter, 2015, Journal of clinical hypertension.

Original Research Using theory to predict implementation of a physician-pharmacist collaborative intervention within a practice-based research network

C. Coffey, B. Carter, G. Ardery, 2013 .

Incremental Costs Associated with Physician and Pharmacist Collaboration to Improve Blood Pressure Control

B. Carter, G. Ardery, J. Brooks, 2012, Pharmacotherapy.

Sustained Blood Pressure Control Following Discontinuation of a Pharmacist Intervention

W. Doucette, E. Chrischilles, B. Carter, 2011, Journal of clinical hypertension.

Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence.

J. W. F. Mil, B. Carter, J. W. Foppe van Mil, 2010, American journal of hypertension.

Deterioration of Blood Pressure Control After Discontinuation of a Physician‐Pharmacist Collaborative Intervention

W. Doucette, E. Chrischilles, B. Carter, 2010, Pharmacotherapy.

Evaluation of Hypertensive Patients after Care Provided by Community Pharmacists in a Rural Setting

E. Chrischilles, B. Carter, G. Mazzotti, 1997, Pharmacotherapy.

22 – Diuretics in Hypertension

M. Ernst, B. Carter, 2018 .

The Relationship between Drug Therapy Noncompliance and Patient Characteristics, Health‐Related Quality of Life, and Health Care Costs

D. Malone, B. Carter, S. Billups, 2000, Pharmacotherapy.

Dissemination of a telehealth cardiovascular risk service: The CVRS live protocol.

B. Levy, J. Dawson, Liz Hollingworth, 2021, Contemporary clinical trials.

Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium.

R. Grimm, Shimin Zheng, M. Ernst, 2010, American journal of hypertension.

Self-identified barriers to rural mental health services in Iowa by older adults with multiple comorbidities: qualitative interview study

B. Carter, K. Kennelty, L. Pass, 2019, BMJ Open.

Current recommendations of the joint national high blood pressure committee.

B. Carter, 1993, Clinical pharmacy.

Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices

Linnea A. Polgreen, Brian M. Gryzlak, B. Levy, 2018, Circulation. Cardiovascular quality and outcomes.

Guidelines for Use of Diuretics: A View From a Member of JNC 7

B. Carter, 2012, Journal of clinical hypertension.

How Pharmacists Can Assist Physicians With Controlling Blood Pressure

W. Elliott, B. Carter, A. Zillich, 2003, Journal of clinical hypertension.

Clinical and Economic Impact of Ambulatory Care Clinical Pharmacists in Management of Dyslipidemia in Older Adults: The IMPROVE Study

D. Malone, D. Covey, B. Mason, 2000 .

Influential Characteristics of Physician/Pharmacist Collaborative Relationships

William R Doucette, Alan J Zillich, W. Doucette, 2004, The Annals of pharmacotherapy.

Formation of a primary care pharmacist practice-based research network.

J. Gums, A. Hume, B. Carter, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Evaluation of the Iowa Medicaid pharmaceutical case management program.

L. Rubenstein, E. Chrischilles, B. Carter, 2004, Journal of the American Pharmacists Association : JAPhA.

The IMPROVE study: Background and study design

D. Malone, B. Carter, R. Valuck, 1998 .

Clinical pharmacy practice in the noninstitutional setting: A white paper from the American College of Clinical Pharmacy

N. Schultz, M. O’Connell, J. Dasta, 1992 .

Development and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective.

W. Doucette, B. Carter, A. Zillich, 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones

B. Carter, G. Ardery, 2016, Journal of the American Heart Association.

Collaborative care model for hypertension

B. Carter, 2018, Journal of clinical hypertension.

Why Physicians Do Not Prescribe a Thiazide Diuretic

P. Kaboli, B. Carter, E. Sutton, 2010, Journal of clinical hypertension.

Fixed‐Dosed Combinations Are Not Indicated as Initial Therapy: A Debate

B. Carter, 2009, Journal of clinical hypertension.

Optimizing delivery systems to tailor pharmacotherapy to cardiovascular circadian events.

B. Carter, 1998, American Journal of Health-System Pharmacy.

Effect of Self‐Efficacy and Social Support on Adherence to Antihypertensive Drugs

B. Carter, Yinghui Xu, C. A. Weber, 2010, Pharmacotherapy.

Elevated Serum Carbamazepine Concentrations following Diltiazem Initiation

B. Carter, M. Eimer, 1987, Drug intelligence & clinical pharmacy.

Cluster randomized trials for pharmacy practice research

E. Foster, B. Carter, T. Gums, 2016, International Journal of Clinical Pharmacy.

Bioavailability of Phenytoin Administered with Antacids

B. Carter, J. Pellock, W. Garnett, 1979 .

Effect of Antacids on Phenytoin Bioavailability

J. R. Howell, B. Carter, J. Pellock, 1981, Therapeutic Drug Monitoring.

How Well Does a Shortened Time Interval Characterize Results of a Full Ambulatory Blood Pressure Monitoring Session?

Michelle A. O'Connor, G. Bergus, J. Dawson, 2008, Journal of clinical hypertension.

Development of a chronic disease indicator score using a Veterans Affairs Medical Center medication database. IMPROVE Investigators.

D. Malone, B. Carter, R. Valuck, 1999, Journal of clinical epidemiology.

Chapter 92 – Adherence, Quality of Life, Cost Effectiveness, and the Role of the Pharmacist

B. Carter, 2007 .

Utility of a questionnaire to measure physician-pharmacist collaborative relationships.

William R Doucette, Alan J Zillich, W. Doucette, 2006, Journal of the American Pharmacists Association : JAPhA.

Effect of a care transition intervention by pharmacists: an RCT

J. Dawson, P. Kaboli, K. Farris, 2014, BMC Health Services Research.

Acceptance of Recommendations by Inpatient Pharmacy Case Managers: Unintended Consequences of Hospitalist and Specialist Care

J. Dawson, P. Kaboli, K. Farris, 2013, Pharmacotherapy.

Antihypertensive drug-prescribing patterns of internists and family physicians.

L. Steinkraus, B. Carter, R. Knudson, 1989, The Journal of family practice.

Therapy of acute thromboembolism with heparin and warfarin.

B. Carter, 1991, Clinical pharmacy.

Have we been true to Paul Parker's vision? Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy remarks

B. Carter, 2019, Journal of the American College of Clinical Pharmacy.

DESCRIPTIVE REPORT Description of a Formal Affiliation Between a School of Pharmaçy and a Managed Care Organization

M. Raebel, B. Carter, Jan Anderson, 1999 .

Can Clinical Pharmacists Affect SF-36 Scores in Veterans at High Risk for Medication-Related Problems?

D. Malone, D. Covey, B. Carter, 2001, Medical care.

An Economic Analysis of a Randomized, Controlled, Multicenter Study of Clinical Pharmacist Interventions for High‐Risk Veterans: The IMPROVE Study

D. Malone, D. Covey, B. Carter, 2000, Pharmacotherapy.

The IMPROVE study: background and study design. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.

D. Malone, B. Carter, R. Valuck, 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Effect of a Physician/Pharmacist Collaborative Care Model on Time in Target Range for Systolic Blood Pressure: Post Hoc Analysis of the CAPTION Trial

Dave L Dixon, L. Buckley, B. V. Van Tassell, 2021, Hypertension.

A centralized cardiovascular risk service to improve guideline adherence in private primary care offices.

Linnea A. Polgreen, Brian M. Gryzlak, B. Levy, 2015, Contemporary clinical trials.

Development and Reliability Testing of the Clinical Pharmacist Recommendation Taxonomy

P. Kaboli, B. Carter, A. Hoth, 2007, Pharmacotherapy.

Reduction in Adverse Symptoms as Blood Pressure Becomes Controlled

K. Farris, B. Carter, Yinghui Xu, 2008, Pharmacotherapy.

Reduced Quality of Life in Veterans at Risk for Drug‐Related Problems

D. Malone, D. Covey, B. Carter, 2001, Pharmacotherapy.

Evaluation of three dosage-prediction methods for initial in-hospital stabilization of warfarin therapy.

B. Carter, J. Taylor, A. Becker, 1987, Clinical pharmacy.